Dupilumab-induced erythema nodosum
Sign Up to like & getrecommendations! Published in 2022 at "JAAD Case Reports"
DOI: 10.1016/j.jdcr.2021.11.007
Abstract: AD: atopic dermatitis EN: erythema nodosum IL: interleukin INTRODUCTION Dupilumab is a fully human monoclonal antibody that functions as an interleukin (IL) 4a receptor antagonist, inhibiting the activity of both IL-4 and IL13, drivers of… read more here.
Keywords: erythema nodosum; induced erythema; dupilumab induced;
Dupilumab-induced hypereosinophilia: review of the literature and algorithm proposal for clinical management
Sign Up to like & getrecommendations! Published in 2022 at "Expert Review of Respiratory Medicine"
DOI: 10.1080/17476348.2022.2090342
Abstract: ABSTRACT Introduction Dupilumab is a human monoclonal antibody that targets both IL-4 and IL-13 signaling. It is currently indicated for the treatment of asthma, moderate-to-severe atopic dermatitis, and chronic rhinosinusitis with nasal polyps (CRSwNP). Eosinophilia… read more here.
Keywords: management dupilumab; induced hypereosinophilia; review; dupilumab induced ... See more keywords
Multicenter prospective observational study of dupilumab‐induced ocular events in atopic dermatitis patients
Sign Up to like & getrecommendations! Published in 2023 at "Journal of the European Academy of Dermatology and Venereology"
DOI: 10.1111/jdv.18932
Abstract: Although ocular adverse events are frequent in AD patients treated with dupilumab, their characterization remains limited due to a lack of prospective studies with a systematic ophthalmological examination. read more here.
Keywords: multicenter prospective; induced ocular; observational study; study dupilumab ... See more keywords
Dupilumab-induced ocular surface disease: a primer
Sign Up to like & getrecommendations! Published in 2022 at "BMJ Case Reports"
DOI: 10.1136/bcr-2022-249019
Abstract: The management of atopic diseases has been revolutionised by precision therapies and biological drugs that target specific immune proteins. This report elucidates a unique complication from the use of the monoclonal antibody, dupilumab, that primary… read more here.
Keywords: disease; induced ocular; surface disease; dupilumab induced ... See more keywords
Dupilumab-induced Acute Generalized Exanthematous Pustulosis in a 17-year-old Female Chinese Patient with Atopic Dermatitis
Sign Up to like & getrecommendations! Published in 2022 at "Acta Dermato-Venereologica"
DOI: 10.2340/actadv.v102.1079
Abstract: Abstract is missing (Short communication) read more here.
Keywords: induced acute; pustulosis year; generalized exanthematous; dupilumab induced ... See more keywords